| 302644 |
United Kingdom |
LGC AXIO Proficiency Testing
LGC AXIO Proficiency Testing
|
Environmental Hygiene Monitoring Scheme- HYGIENE
Environmental Hygiene Monitoring Scheme- HYGIENE
|
2021-09-06 |
|
|
| Test item |
(Surface testing (swab rinsate) for SARS-CoV-2 molecular) |
| Tested property |
(SARS-CoV-2) |
|
| 696054 |
Germany |
DRRR - Deutsches Referenzbüro für Ringversuche und Referenzmaterialien GmbH
DRRR - Deutsches Referenzbüro für Ringversuche und Referenzmaterialien GmbH
|
Medical face masks (EN 14683) / filtering half masks (EN 149)
[Medizinische Gesichtsmasken (EN 14683) / Filtrierende Halbmasken (EN 149)]
Medical face masks (EN 14683) / filtering half masks (EN 149)
[Medizinische Gesichtsmasken (EN 14683) / Filtrierende Halbmasken (EN 149)]
|
2021-10-29 |
|
|
| Remarks |
(PT relevant to SARS-CoV-2 virus / COVID-19) |
|
| 907768 |
Germany |
Institut für Qualitätssicherung Lübeck (IfQ-Lübeck)
Institut für Qualitätssicherung Lübeck (IfQ-Lübeck)
|
Antibodies against SARS-CoV-2
[Antikörper gegen SARS-CoV-2]
Antibodies against SARS-CoV-2
[Antikörper gegen SARS-CoV-2]
|
2021-11-25 |
|
|
| PT name |
(Antibodies against SARS-CoV-2) |
| Scheme name in national language |
(Antikörper gegen SARS-CoV-2) |
| Tested property |
(Anti-SARS-CoV-2 (NCP) IgG) (Anti-SARS-CoV-2 (S1) IgG) |
|
| 910247 |
Brazil |
ControlLab Controle de Qualidade para Laboratórios Ltda
ControlLab Controle de Qualidade para Laboratórios Ltda
|
Clinical PT - RLT Molecular Biology Coronavírus (SARS-CoV2)
[EP Clínico - TLR Biologia Molecular Coronavírus (SARS-CoV2) ]
Clinical PT - RLT Molecular Biology Coronavírus (SARS-CoV2)
[EP Clínico - TLR Biologia Molecular Coronavírus (SARS-CoV2) ]
|
2021-12-06 |
|
|
| PT name |
(Clinical PT - RLT Molecular Biology Coronavírus (SARS-CoV2)) |
| Scheme name in national language |
(EP Clínico - TLR Biologia Molecular Coronavírus (SARS-CoV2)) |
| Tested property |
(Coronavírus (SARS-CoV2)) |
|
| 769005 |
United Kingdom |
LGC AXIO Proficiency Testing
LGC AXIO Proficiency Testing
|
SARS-CoV-2 Proficiency Testing Scheme
SARS-CoV-2 Proficiency Testing Scheme
|
2022-05-04 |
|
|
| PT name |
(SARS-CoV-2 Proficiency Testing Scheme) |
| Test item |
(SARS-CoV-2 (Serological)- 3 x 0.75 ml samples for detection for the SARS-CoV-2 antibodies -NEW 2020) (SARS-CoV-2 (Molecular)- 2 x 1.5ml samples for SARS-CoV-2 virus -NEW 2020) (SARS-CoV-2 antigen - 3 x swab based samples (A, B, and C). Non-infectious simulated patient) (nasopharyngeal samples containing the SARS-CoV-2 nucleocapsid protein.) (SARS-CoV-2 (Molecular)- 2 x swab based samples. Non-infectious simulated nasopharyngeal samples) |
| Tested property |
(SARS-CoV-2 IgA, IgG, IgM, Total antibodies) (SARS-CoV-2 virus) (SARS-CoV-2 virus) (SARS-CoV-2 virus - The samples contain the whole genome) (SARS-CoV-2 virus - The samples contain the whole genome) |
| Testing method |
(The samples are derived from naturally occurring material collected via apheresis from patients that have recovered from COVID-19.) |
|
| 935187 |
Brazil |
ControlLab Controle de Qualidade para Laboratórios Ltda
ControlLab Controle de Qualidade para Laboratórios Ltda
|
Clinical PT - Rapid Diagnostic Test - Neutralizing Antibody Research: Coronavirus (SARS-CoV2)
[EP Clínico - Teste Rápido - Pesquisa de Anticorpos Neutralizantes: Coronavírus (SARS-CoV2)]
Clinical PT - Rapid Diagnostic Test - Neutralizing Antibody Research: Coronavirus (SARS-CoV2)
[EP Clínico - Teste Rápido - Pesquisa de Anticorpos Neutralizantes: Coronavírus (SARS-CoV2)]
|
2022-05-12 |
|
|
| PT name |
(Clinical PT - Rapid Diagnostic Test - Neutralizing Antibody Research: Coronavirus (SARS-CoV2)) |
| Scheme name in national language |
(EP Clínico - Teste Rápido - Pesquisa de Anticorpos Neutralizantes: Coronavírus (SARS-CoV2)) |
| Tested property |
(RDT - Neutralizing Antibody Research: Coronavirus (SARS-CoV2)) |
|
| 925094 |
United Kingdom |
UK NEQAS for Microbiology
UK NEQAS for Microbiology
|
Molecular detection of SARS-CoV-2
[Molecular detection of SARS-CoV-2]
Molecular detection of SARS-CoV-2
[Molecular detection of SARS-CoV-2]
|
2022-05-13 |
|
|
| PT name |
(Molecular detection of SARS-CoV-2) |
| Scheme name in national language |
(Molecular detection of SARS-CoV-2) |
| Test item |
(/ absence of SARS-CoV-2 nucleic acid by molecular methods, genotyping of SARS-CoV-2 (if performed)) |
| Tested property |
(SARS-CoV-2 nucleic acid) |
|
| 935461 |
United Kingdom |
UK NEQAS for Microbiology
UK NEQAS for Microbiology
|
SARS-CoV-2 Point of Care
[SARS-CoV-2 Point of Care]
SARS-CoV-2 Point of Care
[SARS-CoV-2 Point of Care]
|
2022-05-13 |
|
|
| PT name |
(SARS-CoV-2 Point of Care) |
| Scheme name in national language |
(SARS-CoV-2 Point of Care) |
| Tested property |
(To determine the presence / absence of SARS-CoV-2 antigen/ nucleic acid by point of care devices such as lateral flow, LAMP and antigen test) |
|
| 837442 |
Brazil |
PROGRAMA NACIONAL DE CONTROLE DE QUALIDADE
PROGRAMA NACIONAL DE CONTROLE DE QUALIDADE
|
COVID-19 (SARS-CoV2) IMUNOCROMATOGRAFIA
[COVID-19 (SARS-CoV2) IMUNOCROMATOGRAFIA]
COVID-19 (SARS-CoV2) IMUNOCROMATOGRAFIA
[COVID-19 (SARS-CoV2) IMUNOCROMATOGRAFIA]
|
2022-05-30 |
|
|
| PT name |
(COVID-19 (SARS-CoV2) IMUNOCROMATOGRAFIA) |
| Scheme name in national language |
(COVID-19 (SARS-CoV2) IMUNOCROMATOGRAFIA) |
|
| 947164 |
Brazil |
ControlLab Controle de Qualidade para Laboratórios Ltda
ControlLab Controle de Qualidade para Laboratórios Ltda
|
Clinical PT - Coronavirus (SARS-CoV2): antigen research by automation
[EP Clínico - Coronavírus (SARS-CoV2): pesquisa de antígeno por automação]
Clinical PT - Coronavirus (SARS-CoV2): antigen research by automation
[EP Clínico - Coronavírus (SARS-CoV2): pesquisa de antígeno por automação]
|
2022-07-26 |
|
|
| PT name |
(Clinical PT - Coronavirus (SARS-CoV2): antigen research by automation) |
| Scheme name in national language |
(EP Clínico - Coronavírus (SARS-CoV2): pesquisa de antígeno por automação) |
| Tested property |
(Coronavirus (SARS-CoV2): antigen research by automation) |
|
| 880833 |
Brazil |
ControlLab Controle de Qualidade para Laboratórios Ltda
ControlLab Controle de Qualidade para Laboratórios Ltda
|
Clinical PT - Molecular panel of Respiratory Infections and Pneumonia
[EP Clínico - Painel Molecular para Infecções Respiratórias e Pneumonias]
Clinical PT - Molecular panel of Respiratory Infections and Pneumonia
[EP Clínico - Painel Molecular para Infecções Respiratórias e Pneumonias]
|
2022-09-23 |
|
|
| Tested property |
(Coronavírus (SARS-CoV-2)) |
|
| 705717 |
Brazil |
ControlLab Controle de Qualidade para Laboratórios Ltda
ControlLab Controle de Qualidade para Laboratórios Ltda
|
Clinical PT - Molecular Biology Coronavírus (SARS-CoV2)
[EP Clínico - Biologia Molecular Coronavírus (SARS-CoV2)]
Clinical PT - Molecular Biology Coronavírus (SARS-CoV2)
[EP Clínico - Biologia Molecular Coronavírus (SARS-CoV2)]
|
2023-01-31 |
|
|
| PT name |
(Clinical PT - Molecular Biology Coronavírus (SARS-CoV2)) |
| Scheme name in national language |
(EP Clínico - Biologia Molecular Coronavírus (SARS-CoV2)) |
| Tested property |
(Coronavírus (SARS-CoV2)) |
|
| 1009007 |
Brazil |
ControlLab Controle de Qualidade para Laboratórios Ltda
ControlLab Controle de Qualidade para Laboratórios Ltda
|
Clinical PT - Molecular Biology - Coronavirus (SARS-CoV2): saliva
[EP Clínico - Biologia Molecular Coronavírus (SARS-CoV2): saliva]
Clinical PT - Molecular Biology - Coronavirus (SARS-CoV2): saliva
[EP Clínico - Biologia Molecular Coronavírus (SARS-CoV2): saliva]
|
2023-01-31 |
|
|
| PT name |
(Clinical PT - Molecular Biology - Coronavirus (SARS-CoV2): saliva) |
| Scheme name in national language |
(EP Clínico - Biologia Molecular Coronavírus (SARS-CoV2): saliva) |
| Tested property |
(Molecular Biology - Coronavirus (SARS-CoV2): saliva) |
|
| 705758 |
Brazil |
ControlLab Controle de Qualidade para Laboratórios Ltda
ControlLab Controle de Qualidade para Laboratórios Ltda
|
Clinical PT - TLR Immunology Coronavírus (SARS-CoV2)
[EP Clínico - TLR Imunologia Coronavírus (SARS-CoV2)]
Clinical PT - TLR Immunology Coronavírus (SARS-CoV2)
[EP Clínico - TLR Imunologia Coronavírus (SARS-CoV2)]
|
2023-01-31 |
|
|
| PT name |
(Clinical PT - TLR Immunology Coronavírus (SARS-CoV2)) |
| Scheme name in national language |
(EP Clínico - TLR Imunologia Coronavírus (SARS-CoV2)) |
|
